A cell (red) infected with SARS-CoV-2 particles (green).Credit: NIAID/NIH/SPL Researchers developing the Oxford–AstraZeneca COVID-19 vaccine have identified biomarkers that can help to predict whether someone will be protected by the jab they receive. The team at the University of Oxford, UK, identified a ‘correlate of protection from the immune responses of trial participants — the...
Ewen Callaway A cell (red) infected with SARS-CoV-2 particles (green).Credit: NIAID/NIH/SPL Researchers developing the Oxford–AstraZeneca COVID-19 vaccine have identified biomarkers that can help to predict whether someone will be protected by the jab they receive. The team at the University of Oxford, UK, identified a ‘correlate of protection from the immune responses of trial participants —...
